Episode 25: Digestive Health: Oshi Health’s clinical, whole-person view

Sam Holliday, Chantell Sell and Steve Blumenfield discuss Oshi Health, an end-to-end clinic-based care model that treats the whole person in a cost-effective way that serves employees, employers, and boosts overall health and productivity.

Opportunities & challenges in digestive diseases research: Recommendations of the National Commission on Digestive Diseases

The epidemiology, diagnosis, and cost of dyspepsia and helicobater pylori gastritis: A case–control analysis in the southwestern United States

Many patients continue using proton pump inhibitors after negative results from tests for reflux disease

The quality of care for gastroesophageal reflux disease

The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease

White paper AGA: Optimal strategies to define and diagnose gastroesophageal reflux disease

Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: A prospective intervention trial

Lifestyle intervention in gastroesophageal reflux disease

A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome

Is irritable bowel syndrome a diagnosis of exclusion? A survey of primary care providers, gastroenterologists, and IBS experts

Report from Brennan M. R. Spiegel, MD, MSHS: Diagnostic testing in irritable bowel syndrome: Theory vs. reality

Variation in care for patients with irritable bowel syndrome in the United States

Psychological therapies in patients with irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials

The role of diet in irritable bowel syndrome: Implications for dietary advice

Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): An open-label, single-centre, randomised controlled trial

Systematic review: Impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares

Effect of tight control management on Crohn’s disease (CALM): a multicentre, randomised, controlled phase 3 trial

E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘constant-care’ approach

Find lasting relief from digestive issues

Get Started